Sprycel

Sprycel Indications/Uses

dasatinib

Manufacturer:

Bristol-Myers Squibb

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
SPRYCEL (dasatinib) is indicated for the treatment of adults with newly diagnosed chronic myeloid leukemia (CML) in chronic phase; chronic, accelerated, or myeloid or lymphoid blast phase CML with resistance or intolerance to prior therapy including imatinib; Philadelphia chromosome-positive acute lymphobastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy including imatinib.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in